全文获取类型
收费全文 | 229篇 |
免费 | 25篇 |
国内免费 | 8篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 17篇 |
口腔科学 | 3篇 |
临床医学 | 9篇 |
内科学 | 16篇 |
神经病学 | 1篇 |
特种医学 | 2篇 |
外科学 | 5篇 |
综合类 | 18篇 |
预防医学 | 9篇 |
药学 | 92篇 |
中国医学 | 22篇 |
肿瘤学 | 67篇 |
出版年
2023年 | 7篇 |
2022年 | 10篇 |
2021年 | 7篇 |
2020年 | 7篇 |
2019年 | 6篇 |
2018年 | 1篇 |
2017年 | 9篇 |
2016年 | 13篇 |
2015年 | 11篇 |
2014年 | 20篇 |
2013年 | 31篇 |
2012年 | 15篇 |
2011年 | 19篇 |
2010年 | 13篇 |
2009年 | 19篇 |
2008年 | 13篇 |
2007年 | 14篇 |
2006年 | 6篇 |
2005年 | 7篇 |
2004年 | 5篇 |
2003年 | 4篇 |
2002年 | 1篇 |
2000年 | 1篇 |
1999年 | 5篇 |
1998年 | 5篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1983年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有262条查询结果,搜索用时 15 毫秒
1.
目的 探讨抗癌生物活性肽(ACBP)对人乳腺癌 nm231细胞的作用及其机制。 方法 nm231 细胞经不同浓度(0.05、0.10、0.20、 0.25 µg/ml)ACBP 作用 72 h,以噻唑蓝(MTT)法测定细胞增殖活性。以 0.25 µg/ml 的 ACBP 分别作用于 nm231 细胞 4、6、24、48、72 h,行光镜和透射电镜(作用 48 h 细胞)观察。应用 DNA 凝胶电泳和磷脂结合蛋白 V(Annexin V,AV)/碘化丙啶(PI)双标记染色流式细胞术等方法,观察 0.25 µg/ml 的 ACBP 作用不同时间对nm231 细胞凋亡发生及作用 48 h 对细胞周期的影响。以上各项检测均设以 RPMI 1640 培养液取代 ACBP 的对照组。 结果 浓度为 0.1 µg/ml 的 ACBP 即对 nm231 细胞的增殖有明显抑制作用,抑制率为 10.3%,抑制作用具有浓度依赖性,ACBP 浓度为 0.25 µg/ml 时抑制率达 35.1%。光镜观察显示,经 0.25 µg/ml 的 ACBP 作用 24 h,细胞出现凋亡特征;作用 48 h,光镜及电镜下均可见大量的典型凋亡细胞。DNA 凝胶电泳显示,经 0.25 µg/ml 的ACBP 作用 24 h 的细胞出现 DNA 断裂;作用 48 h 的细胞出现典型的梯形电泳图谱。流式细胞术分析显示,ACBP 作用后AV(+)/ PI(-)细胞和 AV(+)/ PI(+)细胞比例均随培养时间延长而增大;作用 48 h 的 nm231细胞 G0/1 期细胞比例高于对照组(P < 0.01),而细胞增殖指数低于对照组(P < 0.01)。 结论 ACBP 可抑制 nm231 细胞的增殖,其机制与抑制nm231 细胞的 DNA 合成和诱导细胞凋亡相关。 相似文献
2.
抗癌胶囊对实验性肿瘤的治疗及对化疗减毒作用研究 总被引:4,自引:1,他引:4
目的:研究抗癌胶囊对小鼠移植肿瘤S180,H22,Lewis的抑瘤作用及对化疗药所致小鼠免疫功能抑制的保护作用。方法:按照抗癌药物筛选规程进行体内抑瘤实验:采用氟尿嘧啶(FU)制备免疫功能低下模型,测定抗癌胶囊对小鼠白细胞计数、免疫器官重量、腹腔巨噬细胞吞噬功能和NK细胞的影响。结果:抗癌胶囊对小鼠移植肿瘤S180,H22,Lewis均有不同的抑瘤作用,其中高剂量组抑瘤效果最佳,并对小鼠体重生长无明显影响。抗癌胶囊还有明显拮抗FU所致白细胞下降,胸腺、脾脏萎缩,腹腔巨噬细胞功能降低和NK细胞减少等毒副作用。结论:抗癌胶囊具有明显的抗肿瘤作用。 相似文献
3.
OBJECTIVETo investigate anti-cancer of the Anti-cancer Oral Liquid (ACOL) for MGC-803 gastric cancer cell line in vivo and vitro. METHODUsing the MTT assay, colonogenic assay and sero-pharmacological experiment by treating with the Chinese traditional med 相似文献
4.
目的探讨人肺癌细胞体外对10种抗癌药的敏感性及方法的可靠性。方法收集人肺癌手术切除的标本20例,用一简单、快速,有一定特异性优点的MTT(3-(4,5)-双甲基-2-唑噻-(2,5)-二苯基溴化四氮唑蓝)法作威猛、足叶乙甙、阿霉素、长春新碱、长春地辛、卡铂、平阳霉素、氟脲嘧啶、环磷酰胺和异环磷酰胺抗癌敏感药物试验。结果患者不同个体之间药物敏感性不同(P<0.01):10种药物平均抑制率以威猛类药物最高(P<0.01),依次为阿霉素、卡铂、足叶乙甙、长春地辛等。敏感药物顺序与临床治疗结果大致相符。结论用MTT法可作肿瘤治疗个案化较为可靠的检测方法。 相似文献
5.
6.
p53肿瘤抑制蛋白,也被称为基因组监控因子,是一种保护细胞免受一系列生理逆境(例如致癌基因活化、辐射、有丝分裂压力、核糖体压力和化学损害)的转录控制因子.这些生理逆境会导致依赖于p53激活的信号产生,并通过复杂的相互作用网络定位到细胞核,起始转录或抑制许多基因的表达,这些基因与诱导生长停滞、修复、细胞凋亡、衰老或者改变新陈代谢有关.由于p53途径对于调控疾病有如此重要的作用,使得针对该途径的药物干预日益成为人们关注的焦点.本文对调节p53功能的最新研究进展进行综述,并对有关p53基因的癌症治疗前景进行展望. 相似文献
7.
Mi Seon Kim Yunmi Lee Gi-Ho Sung Ji Hye Kim Jae Gwang Park Han Gyung Kim Kwang Soo Baek Jae Han Cho Jaegu Han Kang-Hyo Lee Sungyoul Hong Jong-Hoon Kim Jae Youl Cho 《Biomolecules & therapeutics.》2015,23(4):367-373
Cordyceps species including Cordyceps bassiana are a notable anti-cancer dietary supplement. Previously, we identified several compounds with anti-cancer activity from the butanol fraction (Cb-BF) of Cordyceps bassiana. To expand the structural value of Cb-BF-derived anti-cancer drugs, we employed various chemical moieties to produce a novel Cb-BF-derived chemical derivative, KTH-13-amine-monophenyl [4-isopropyl-2-(1-phenylethyl) aniline (KTH-13-AMP)], which we tested for anti-cancer activity. KTH-13-AMP suppressed the proliferation of MDA-MB-231, HeLa, and C6 glioma cells. KTH-13-AMP also dose-dependently induced morphological changes in C6 glioma cells and time-dependently increased the level of early apoptotic cells stained with annexin V-FITC. Furthermore, the levels of the active full-length forms of caspase-3 and caspase-9 were increased. In contrast, the levels of total forms of caspases-3, caspase-8, caspase-9, and Bcl-2 were decreased in KTH-13-AMP treated-cells. We also confirmed that the phosphorylation of STAT3, Src, and PI3K/p85, which is linked to cell survival, was diminished by treatment with KTH-13-AMP. Therefore, these results strongly suggest that this compound can be used to guide the development of an anti-cancer drug or serve as a lead compound in forming another strong anti-proliferative agent. 相似文献
8.
Anas Ahmad Rakesh Kumar Mishra Akshay Vyawahare Ajay Kumar Muneeb U. Rehman Wajhul Qamar Abdul Quaiyoom Khan Rehan Khan 《Saudi Pharmaceutical Journal》2019,27(8):1113-1126
Cancer remains the topmost disorder of the mankind and number of cases is unceasingly growing at unprecedented rates. Although the synthetic anti-cancer compounds still hold the largest market in the modern treatment of cancer, natural agents have always been tried and tested for potential anti-cancer properties. Thymoquinone (TQ), a monoterpene and main ingredient in the essential oil of Nigella sativa L. has got very eminent rankings in the traditional systems of medicine for its anti-cancer pharmacological properties. In this review we summarized the diverse aspects of TQ including its chemistry, biosynthesis, sources and pharmacological properties with a major concern being attributed to its anti-cancer efficacies. The role of TQ in different aspects involved in the pathogenesis of cancer like inflammation, angiogenesis, apoptosis, cell cycle regulation, proliferation, invasion and migration have been described. The mechanism of action of TQ in different cancer types has been briefly accounted. Other safety and toxicological aspects and some combination therapies involving TQ have also been touched. A detailed literature search was carried out using various online search engines like google scholar and pubmed regarding the available research and review accounts on thymoquinone upto may 2019. All the articles reporting significant addition to the activities of thymoquinone were selected. Additional information was acquired from ethno botanical literature focusing on thymoquinone. The compound has been the centre of attention for a long time period and researched regularly in quite considerable numbers for its various physicochemical, medicinal, biological and pharmacological perspectives. Thymoquinone is studied for various chemical and pharmacological activities and demonstrated promising anti-cancer potential. The reviewed reports confirmed the strong anti-cancer efficacy of thymoquinone. Further in-vitro and in-vivo research is strongly warranted regarding the complete exploration of thymoquinone in ethnopharmacological context. 相似文献
9.
Adil Farooq Wali Sabhiya Majid Shabhat Rasool Samar Bassam Shehada Shahad Khalid Abdulkareem Aimen Firdous Saba Beigh Sheeba Shakeel Saima Mushtaq Imra Akbar Hassan Madhkali Muneeb U. Rehman 《Saudi Pharmaceutical Journal》2019,27(6):767-777
Marine natural products have as of now been acknowledged as the most important source of bioactive substances and drug leads. Marine flora and fauna, such as algae, bacteria, sponges, fungi, seaweeds, corals, diatoms, ascidian etc. are important resources from oceans, accounting for more than 90% of the total oceanic biomass. They are taxonomically different with huge productive and are pharmacologically active novel chemical signatures and bid a tremendous opportunity for discovery of new anti-cancer molecules. The water bodies a rich source of potent molecules which improve existence suitability and serve as chemical shield against microbes and little or huge creatures. These molecules have exhibited a range of biological properties antioxidant, antibacterial, antitumour etc. In spite of huge resources enriched with exciting chemicals, the marine floras and faunas are largely unexplored for their anticancer properties. In recent past, numerous marine anticancer compounds have been isolated, characterized, identified and are under trials for human use. In this write up we have tried to compile about marine-derived compounds anticancer biological activities of diverse flora and fauna and their underlying mechanisms and the generous raise in these compounds examined for malignant growth treatment in the course of the most recent quite a long while. 相似文献
10.
Anti-Proliferative and Apoptosis-Inducing Activity of Acacia Modesta and Opuntia Monocantha Extracts on HeLa Cells
下载免费PDF全文
![点击此处可从《Asian Pacific journal of cancer prevention》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Farah Abid Muhammad SaleemChristian D. MullerMulazim Hussain AsimShumaila ArshadTahir MaqboolFaheem Hadi 《Asian Pacific journal of cancer prevention》2020,21(10):3125-3131
Background: Cancer is one of the leading causes of death in the world. Numerous phytochemicals from plants have shown antineoplastic effects via programmed cell death (apoptosis). The aim of this study was to evaluate the effect of anti-proliferative and apoptosis-inducing activity of Acacia modesta and Opuntia monocantha against HeLa cells. Methods: To estimate anti-proliferative activity of the plants against HeLa cells, ethanol solvent was used for the extraction. For the evaluation of anti-proliferative effects, MTT assay was performed with 100, 200, and 400 µg/mL dose. The antioxidant assays including glutathione reductase (GSH), superoxide dismutase (SOD) and catalase were performed. Moreover, enzyme linked immunosorbent assay (ELISA) was performed. Furthermore, immunocytometry P53 and flow cytometry were also carried out to assess the apoptosis in HeLa cell. Results: MTT assay showed that the groups treated with Opuntia monocantha and Acacia modest have less level of toxicity as compared to untreated groups. Antioxidant assays confirmed that GSH, SPD and, catalase activities were quite decreased in treated groups as compared to untreated groups. Similarly, ELISA and apoptosis p53 have shown more pronounced apoptosis effect in treated groups as compared to untreated groups. Conclusion: Based on above findings, treatment of HeLa cells with these plant extracts induced apoptosis, restricts proliferation, and enhances the anti-oxidative index in post treated cells. 相似文献